These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38494931)

  • 1. We Must Abandon the Myth: Oxidized Low-density Lipoprotein is not a Lipoprotein that Plays a Key Role in Atherogenesis.
    Orekhov AN
    Curr Med Chem; 2024 Mar; ():. PubMed ID: 38494931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification.
    Tertov VV; Kaplun VV; Sobenin IA; Orekhov AN
    Atherosclerosis; 1998 May; 138(1):183-95. PubMed ID: 9678784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atherogenic modification of low-density lipoproteins].
    Sukhorukov VN; Karagodin VP; Orekhov AN
    Biomed Khim; 2016 May; 62(4):391-402. PubMed ID: 27562992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple-modified Low-Density Lipoprotein as Atherogenic Factor of Patients' Blood: Development of Therapeutic Approaches to Reduce Blood Atherogenicity.
    Nikiforov NG; Zakiev ER; Elizova NV; Sukhorukov VN; Orekhov AN
    Curr Pharm Des; 2017; 23(6):932-936. PubMed ID: 28120723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of low density lipoprotein isolated from circulating immune complexes.
    Tertov VV; Sobenin IA; Orekhov AN; Jaakkola O; Solakivi T; Nikkari T
    Atherosclerosis; 1996 May; 122(2):191-9. PubMed ID: 8769682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbohydrate composition of circulating multiple-modified low-density lipoprotein.
    Zakiev ER; Sobenin IA; Sukhorukov VN; Myasoedova VA; Ivanova EA; Orekhov AN
    Vasc Health Risk Manag; 2016; 12():379-385. PubMed ID: 27789955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Oxidized Low-Density Lipoprotein a Principal Actor in Atherogenesis?
    Orekhov A; Sukhorukov V; Melnichenko A
    Curr Med Chem; 2024 Jan; ():. PubMed ID: 38185888
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-oxidative
    Orekhov A; Khotina V; Sukhorukov V; Sobenin I
    Curr Med Chem; 2024; 31(17):2309-2313. PubMed ID: 38204226
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxidative modifications of LDL increase its binding to extracellular matrix from human aortic intima: influence of lesion development, lipoprotein lipase and calcium.
    Wang X; Greilberger J; Ratschek M; Jürgens G
    J Pathol; 2001 Sep; 195(2):244-50. PubMed ID: 11592105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid composition of circulating multiple-modified low density lipoprotein.
    Zakiev ER; Sukhorukov VN; Melnichenko AA; Sobenin IA; Ivanova EA; Orekhov AN
    Lipids Health Dis; 2016 Aug; 15(1):134. PubMed ID: 27558696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Phagocytosis in the Pro-Inflammatory Response in LDL-Induced Foam Cell Formation; a Transcriptome Analysis.
    Orekhov AN; Nikiforov NG; Sukhorukov VN; Kubekina MV; Sobenin IA; Wu WK; Foxx KK; Pintus S; Stegmaier P; Stelmashenko D; Kel A; Gratchev AN; Melnichenko AA; Wetzker R; Summerhill VI; Manabe I; Oishi Y
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized-Desialylated Low-Density Lipoprotein Inhibits the Antitumor Functions of Lymphokine Activated Killer Cells.
    Aguilar Díaz de León JS; Glenn HL; Knappenberger M; Borges CR
    J Cancer; 2021; 12(16):4993-5004. PubMed ID: 34234868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Front line of oxidized lipoproteins: role of oxidized lipoproteins in atherogenesis and cardiovascular disease risk].
    Yoshida H
    Rinsho Byori; 2010 Jun; 58(6):622-30. PubMed ID: 20662275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Atherogenic Role of Circulating Modified Lipids in Atherosclerosis.
    Summerhill VI; Grechko AV; Yet SF; Sobenin IA; Orekhov AN
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31330845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant content in low density lipoprotein and lipoprotein oxidation in vivo and in vitro.
    Tertov VV; Sobenin IA; Kaplun VV; Orekhov AN
    Free Radic Res; 1998 Aug; 29(2):165-73. PubMed ID: 9790519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
    Tertov VV; Kaplun VV; Dvoryantsev SN; Orekhov AN
    Biochem Biophys Res Commun; 1995 Sep; 214(2):608-13. PubMed ID: 7677772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.
    Tertov VV; Sobenin IA; Gabbasov ZA; Popov EG; Jaakkola O; Solakivi T; Nikkari T; Smirnov VN; Orekhov AN
    Lab Invest; 1992 Nov; 67(5):665-75. PubMed ID: 1434544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modified LDL and atherosclerosis. Nature of modifications. Physicochemical and biological properties].
    Pech MA; Myara I; Vedie B; Moatti N
    Ann Biol Clin (Paris); 1992; 50(4):213-27. PubMed ID: 1456499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.
    Staprans I; Pan XM; Rapp JH; Feingold KR
    Mol Nutr Food Res; 2005 Nov; 49(11):1075-82. PubMed ID: 16270280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of oxidized low density lipoprotein in atherogenesis.
    Jialal I; Devaraj S
    J Nutr; 1996 Apr; 126(4 Suppl):1053S-7S. PubMed ID: 8642431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.